Robots and Human-Centric AI Dazzle at Opening of BEYOND Expo 2025

Robots and Human-Centric AI Dazzle at Opening of BEYOND Expo 2025

Pioneering Asian tech unveiled as industry leaders call for global cooperation MACAO, May 23, 2025 /PRNewswire/ -- The 5th BEYOND Expo opened it door to visitors today at The Venetian® Macao's Cotai Expo as over 800 pioneering Asian companies and...

i2Cool's Radiative Cooling Technology to Drive Global Sustainability in UN-Backed FIRST Programme

i2Cool's Radiative Cooling Technology to Drive Global Sustainability in UN-Backed FIRST Programme

HONG KONG, May 16, 2025 /PRNewswire/ -- i2Cool is honored to participate in the Fostering Innovation for Resilience and Sustainable Transformation (FIRST ) Programme, a global initiative led by City University of Hong Kong (CityUHK) and officially...

Hyundai MOBIS moves forward with its new 'Move Improved' campaign

Hyundai MOBIS moves forward with its new 'Move Improved' campaign

With a tagline 'Move Improved', advanced mobility technologies are introduced in a joyful and relatable story of driving experience. Through social media launch, it aims to create a better understanding of the Hyundai MOBIS' brand and its mobility...

Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025

Hyundai Mobis to Showcase World's First Full-Windshield Holographic Display at CES 2025

The groundbreaking display projects critical driving information across the entire width of the windshield, offering a panoramic and immersive experience that spans from the driver's seat to the passenger's seat. Hyundai Mobis will also present its...

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)

YOGIN, South Korea, Dec. 18, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as...

menu
menu